California is suing Juul Labs for their role in the youth vaping crisis; a lack of clean water and plumbing was shown to disproportionately affect Native Americans; a chemical plant is passing the permit process in a Louisiana area already dubbed “cancer alley.”
The state of California filed a lawsuit against the e-cigarette manufacturer Juul Labs alleging the company of engaging in a “systematic” and “wildly successful” campaign to attract teenagers to its nicotine devices, according to Reuters. The move draws on internal correspondence showing Juul did little to prevent sales to underage customers, with additional evidence claiming that the company used a flawed age-verification process for online sales. The lawsuit is seeking monetary damages based on violations of state laws such as false advertising and unfair competition.
A report released Monday called “Closing the Water Access Gap in the United States,” showed that more than 2 million Americans live without clean water, with Native Americans being more likely to have trouble accessing water than any other group. NPR reports that for Native American Darlene Yazzie, the closest water station is 9 miles away and the price to fill her 2 gallon barrels is set to rise next month. The report detailed that 58 out of every 1000 Native American households lack plumbing, compared with 3 out of 1000 white households.
Taiwanese plastics company Formosa seems likely to be granted a permit to build a billion-dollar plastics plant in 1 of the most toxic areas of the United States, Louisiana’s so-called “cancer alley”; its proposed emissions are being cited as potentially tripling the levels of cancer-causing chemicals in the air, according to ProPublica. The local community, in the area of the Mississippi River between Baton Rouge and New Orleans, have voiced their objection to the potential move as pollution levels are already dangerously high. Despite these concerns, Formosa permits have been passing in Louisiana’s review process, ProPublica said.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More